Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11029339 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
The site of tumour origin within the left side was not prognostic of outcomes. Moreover, neither bevacizumab nor cetuximab impacted, differently, the findings of the comparisons in outcomes between patients with left-sided colon tumours or rectal cancers.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mohamed E. Salem, Jun Yin, Benjamin A. Weinberg, Lindsay A. Renfro, Levi D. Pederson, Timothy S. Maughan, Richard A. Adams, Eric Van Cutsem, Alfredo Falcone, Niall C. Tebbutt, Matthew T. Seymour, Eduardo DÃaz-Rubio, Enrique Aranda, Carsten Bokemeyer,